ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,359.41
0.56%
Dow Jones
44,756.80
-0.06%
Gold vs US Dollar
2,646.185
0.14%
Brent Oil
73.475
2.20%
Bitcoin
95,745.89
-0.12%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Adaptimmune Therapeutics PLC (ADAP)

  7. Adaptimmune Therapeutics PLC (ADAP) News

Adaptimmune Therapeutics (ADAP)

Adaptimmune Therapeutics PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADAP
DateTimeSourceHeadlineSymbolCompany
13/11/202421:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
13/11/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
13/11/202414:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
01/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
23/09/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
12/08/202411:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ADAPAdaptimmune Therapeutics PLC
12/08/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
12/08/202409:47IH Market NewsU.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices ClimbNASDAQ:ADAPAdaptimmune Therapeutics PLC
02/08/202411:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
02/08/202400:20Business WireAdaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid TumorNASDAQ:ADAPAdaptimmune Therapeutics PLC
16/07/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
18/06/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
11/06/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
15/05/202411:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
15/05/202411:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
14/05/202411:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/03/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
27/02/202413:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
16/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
31/01/202422:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
17/01/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
12/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
12/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ADAPAdaptimmune Therapeutics PLC
04/01/202412:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
06/12/202312:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADAPAdaptimmune Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:ADAP

Your Recent History

EU
PRC
Artmarket.com
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved